40
Participants
Start Date
May 1, 2024
Primary Completion Date
June 30, 2025
Study Completion Date
December 31, 2025
Behavioral Intervention with financial rewards and coaching
Participants will receive variable financial incentives based on their engagement with the continuous glucose monitor and meeting diabetes treatment goals. In addition, they will participate in three motivational interviewing sessions focused on their diabetes management. Participants will continue to receive their diabetes treatment as usual.
Control
Participants will only receive a continuous glucose monitor, which they may engage with as desired and no further intervention. Participants in the control group will continue to receive their diabetes treatment as usual.
RECRUITING
University of Missouri - Kansas City School of Medicine, Kansas City
University of Missouri, Kansas City
OTHER